These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
338 related items for PubMed ID: 29414119
1. Shikonin upregulates the expression of drug-metabolizing enzymes and drug transporters in primary rat hepatocytes. Huang CS, Chen HW, Lin TY, Lin AH, Lii CK. J Ethnopharmacol; 2018 Apr 24; 216():18-25. PubMed ID: 29414119 [Abstract] [Full Text] [Related]
2. Bioavailability of the diterpenoid 14-deoxy-11,12-didehydroandrographolide in rats and up-regulation of hepatic drug-metabolizing enzyme and drug transporter expression. Yen CC, Liu YT, Lin YJ, Yang YC, Chen CC, Yao HT, Chen HW, Lii CK. Phytomedicine; 2019 Aug 24; 61():152841. PubMed ID: 31035043 [Abstract] [Full Text] [Related]
3. Omeprazole induces NAD(P)H quinone oxidoreductase 1 via aryl hydrocarbon receptor-independent mechanisms: Role of the transcription factor nuclear factor erythroid 2-related factor 2. Zhang S, Patel A, Moorthy B, Shivanna B. Biochem Biophys Res Commun; 2015 Nov 13; 467(2):282-7. PubMed ID: 26441083 [Abstract] [Full Text] [Related]
4. Coordinated regulation of hepatic phase I and II drug-metabolizing genes and transporters using AhR-, CAR-, PXR-, PPARα-, and Nrf2-null mice. Aleksunes LM, Klaassen CD. Drug Metab Dispos; 2012 Jul 13; 40(7):1366-79. PubMed ID: 22496397 [Abstract] [Full Text] [Related]
5. The effect of Nrf2 knockout on the constitutive expression of drug metabolizing enzymes and transporters in C57Bl/6 mice livers. Anwar-Mohamed A, Degenhardt OS, El Gendy MA, Seubert JM, Kleeberger SR, El-Kadi AO. Toxicol In Vitro; 2011 Jun 13; 25(4):785-95. PubMed ID: 21281708 [Abstract] [Full Text] [Related]
7. Effect of graded Nrf2 activation on phase-I and -II drug metabolizing enzymes and transporters in mouse liver. Wu KC, Cui JY, Klaassen CD. PLoS One; 2012 Jun 13; 7(7):e39006. PubMed ID: 22808024 [Abstract] [Full Text] [Related]
10. Luteolin modulates expression of drug-metabolizing enzymes through the AhR and Nrf2 pathways in hepatic cells. Zhang T, Kimura Y, Jiang S, Harada K, Yamashita Y, Ashida H. Arch Biochem Biophys; 2014 Sep 01; 557():36-46. PubMed ID: 24914470 [Abstract] [Full Text] [Related]
11. Activation of the aryl hydrocarbon receptor decreases rifampicin-induced CYP3A4 expression in primary human hepatocytes and HepaRG. Rasmussen MK, Daujat-Chavanieu M, Gerbal-Chaloin S. Toxicol Lett; 2017 Aug 05; 277():1-8. PubMed ID: 28571685 [Abstract] [Full Text] [Related]
12. Effect of interferon-α2b on the expression of various drug-metabolizing enzymes and transporters in co-cultures of freshly prepared human primary hepatocytes. Chen C, Han YH, Yang Z, Rodrigues AD. Xenobiotica; 2011 Jun 05; 41(6):476-85. PubMed ID: 21381897 [Abstract] [Full Text] [Related]
13. Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Jigorel E, Le Vee M, Boursier-Neyret C, Parmentier Y, Fardel O. Drug Metab Dispos; 2006 Oct 05; 34(10):1756-63. PubMed ID: 16837569 [Abstract] [Full Text] [Related]
14. Cynaropicrin attenuates UVB-induced oxidative stress via the AhR-Nrf2-Nqo1 pathway. Takei K, Hashimoto-Hachiya A, Takahara M, Tsuji G, Nakahara T, Furue M. Toxicol Lett; 2015 Apr 16; 234(2):74-80. PubMed ID: 25680693 [Abstract] [Full Text] [Related]